-

CORRECTING and REPLACING Nomi Health Opens Covid-19 Testing Site with No Out-of-Pocket Cost with Support from the Kranzberg Arts Foundation and Grand Center, Inc.

Located in Grand Center, the site is open to the public and will support the local arts community including artists, performers and patrons

CORRECTION...by Nomi Health

ST. LOUIS--(BUSINESS WIRE)--Please replace the release dated Oct. 22, 2021 with the following corrected version due to multiple revisions.

The updated release reads:

NOMI HEALTH OPENS COVID-19 TESTING SITE WITH NO OUT-OF-POCKET COST WITH SUPPORT FROM THE KRANZBERG ARTS FOUNDATION AND GRAND CENTER, INC.

Located in Grand Center, the site is open to the public and will support the local arts community including artists, performers and patrons

Nomi Health, the direct healthcare company coordinating COVID-19 testing and vaccination efforts across the country, has opened a new Covid-19 testing site with no out-of-pocket cost to patients in the Grand Center Arts District of St. Louis with support from the Kranzberg Arts Foundation and Grand Center, Inc. Located at 3526 Washington Ave. on the second floor, the testing site is open to the public and will support artists, performers and patrons of the arts in the bustling district by providing both antigen and PCR testing. The site accepts insurance, but for those without insurance, no one will be turned away. Currently, testing wait time onsite is approximately 20-30-minutes, depending on demand.

"Easy access to free Covid testing has been a hindrance to our arts community both on the artist and patron side throughout the pandemic. This new testing site is just one more step in bringing our arts economy back to thriving," said Chris Hansen, Executive Director of the Kranzberg Arts Foundation.

The testing site will be open Monday through Wednesday from 9 a.m. until 7 p.m., Thursday through Saturday from noon until 8 p.m., and on Sunday from noon until 6 p.m. A local call center will be open Monday through Sunday from 8 a.m. until 6 p.m. at (314) 673-8309. For more information or to schedule an appointment, visit http://testing.nomihealth.com/signup/mo.

"This latest site is a part of Nomi Health's continued commitment to keep communities safe and to enable the arts to re-open safely in St. Louis," said Joshua Walker, co-founder and COO, Nomi Health. "Key to us all learning to live with COVID safely is easy access to quality testing, so we are proud to serve St. Louis in this way."

About Nomi Health

Nomi Health is a direct healthcare company focused on making healthcare actually work for those who buy it for their states, organizations, and constituents. We’re a team of over 2,000--each actively working to connect buyers and healthcare providers directly to lower costs, deliver care solutions to all and rewire the health system to run in real time. From the front lines of COVID testing and vaccination serving over 10 million Americans and more than 40,000 patients each day, to building new ecosystems of buyers such as States and Counties without middlemen, Nomi Health delivers a solution for our nation’s leaders seeking to widen access to care while lowering cost of care. Visit us @NomiHealth and www.nomihealth.com.

Customer Service Contact - (314) 673-8309

Contacts

Maggie Habib
MPR, Inc. for Nomi Health
maggie@mpublicrelations.com
(310) 916-6934

Nomi Health


Release Versions

Contacts

Maggie Habib
MPR, Inc. for Nomi Health
maggie@mpublicrelations.com
(310) 916-6934

More News From Nomi Health

CerpassRx Launches AI Engine Powered By Waltz Health to Deliver Real-Time Savings and Spend Management for Specialty Drugs

DALLAS & CHICAGO--(BUSINESS WIRE)--CerpassRx, a leader in pharmacy benefit management (PBM), today announced the launch of the Intelligent Specialty Engine, an AI-enabled platform powered by Waltz Health to manage specialty drug spend. CerpassRx’s innovative approach includes real-time analytics and specialty spend management capabilities that drive significant cost savings, improve transparency and optimize the specialty drug experience for health plan customers and their members – or self-ins...

CareSource and Nomi Health Launch Innovative Partnership to Improve Healthcare Access and Outcomes

DAYTON, Ohio--(BUSINESS WIRE)--CareSource, a non-profit health plan with over 2 million members, has selected Nomi Health to partner with it in launching a new comprehensive effort to help close gaps in healthcare access and outcomes for its Medicaid members across Ohio, Georgia, and Indiana. This collaboration aims to enhance access to essential healthcare services and improve overall health outcomes for people facing barriers to care. "This partnership with Nomi Health represents a significan...

Weight Loss Drugs Weigh Heavy on Employer Health Plans

OREM, Utah--(BUSINESS WIRE)--A meteoric rise in the popularity of glucagon-like peptide-1 (GLP-1) medications such as Ozempic, Wegovy and Mounjaro is creating financial challenges for employer-sponsored health plans. New data from Nomi Health, a company changing healthcare economics, reveals that spending on these diabetes and weight loss drugs went up 253% from 2020 to 2023, surpassing $1 billion last year and making up nearly 10% of total prescription costs for employers. Nomi Health analyzed...
Back to Newsroom